Cargando…
COVID-19 vaccines for high risk and immunocompromised patients
The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat...
Autores principales: | Pavia, Charles S., Plummer, Maria M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797165/ http://dx.doi.org/10.1016/bs.mim.2021.11.001 |
Ejemplares similares
-
COVID-19 Vaccines for HIV-Infected Patients
por: Plummer, Maria M., et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on Easter
por: Pavia, Charles S., et al.
Publicado: (2021) -
COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021) -
Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023) -
Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)